BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18384625)

  • 1. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
    Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
    BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
    Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
    Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
    BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
    BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
    Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
    Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
    Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM
    BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
    Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
    Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
    In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
    BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
    Yamanaka K; Gleave M; Muramaki M; Hara I; Miyake H
    Oncol Rep; 2005 May; 13(5):885-90. PubMed ID: 15809754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Hara I; Kamidono S; Gleave ME
    Clin Cancer Res; 2001 Dec; 7(12):4245-52. PubMed ID: 11751526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells.
    Kamada M; So A; Muramaki M; Rocchi P; Beraldi E; Gleave M
    Mol Cancer Ther; 2007 Jan; 6(1):299-308. PubMed ID: 17218637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer.
    Matsui Y; Hadaschik BA; Fazli L; Andersen RJ; Gleave ME; So AI
    Mol Cancer Ther; 2009 Aug; 8(8):2402-11. PubMed ID: 19625496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
    Jurczok A; Fornara P; Söling A
    BJU Int; 2008 Jan; 101(1):120-4. PubMed ID: 17888045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
    Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
    Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
    Xiao Z; Mak A; Koch K; Moore RB
    BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.